Moreover, blockage of M2 TAMs could reactivate CD8+ T cells against immunosuppressive tumors (Viitala et al., 2019) and infiltrating levels of M2 TAMs in gastric cancer were associated with the 5-year survival rate (Junttila et al., 2020). Here, CD8A is linked to gastric cancer.